Doug Hampton NEW YORK, Sept. 28, 2023 /PRNewswire/ — In keeping with its deep commitment to serving locally and culturally relevant food at its client schools across the nation, Genuine Foods hosted its first ever “Genuine Loves” event in Fletcher, VT. Serving as a debut for this first-of-its kind national program, “Genuine Loves” takes school meals to a … Read more
The collaboration continues BCBSTX’s statewide expansion of Special Beginnings® to improve maternal and infant health outcomes in Texas RICHARDSON, Texas, Sept. 27, 2023 /PRNewswire/ — Health equity researchers at Bracane have begun hosting listening sessions to include community voices and experiences into Blue Cross and Blue Shield of Texas‘ (BCBSTX) expanded Special Beginnings® initiative aimed at improving … Read more
MELBOURNE, Australia and LIEGE, Belgium, Sept. 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) has welcomed Her Royal Highness, Princess Astrid, Princess of Belgium to Telix Manufacturing Solutions (TMS), the Company’s recently inaugurated production facility, in Brussels South (Seneffe) in the Wallonia region of Belgium. Located in the heart of Belgium’s ‘Radiopharma … Read more
BOSTON, Sept. 26, 2023 /PRNewswire/ — Clinical trials utilizing RNAi drug delivery have surged, and BCC Research’s new report “RNAi Drug Delivery: Technologies and Global Markets” predicts just how much the market will grow. Did you know that this year, 2023, marks the 25th anniversary of RNAi’s discovery? Clinical RNAi diagnostic tools and therapies are revolutionizing … Read more
Agreement enables the development of therapeutics, including AcuraStem‘s AS-202 Candidate, an antisense oligonucleotide that suppresses levels of the PIKFYVE kinase MONROVIA, Calif., Sept. 25, 2023 /PRNewswire/ — AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced today that it has entered into a license agreement with Takeda to develop and commercialize … Read more
NEW YORK, Sept. 24, 2023 /PRNewswire/ — The Medical Active Air Sampling System Market size is expected to grow by USD 109.11 million, accelerating at a CAGR of 6.28% during the forecast period. Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their market position. The report also … Read more
—– YL201 Phase I/II Investigators Meeting was successfully held in Guangzhou, China GUANGZHOU, China, Sept. 23, 2023 /PRNewswire/ — On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to participate in the YL201 Phase I/II Investigators Meeting hosted by Suzhou MediLink Therapeutics Co., Ltd. The chair … Read more
SHANGHAI, Sept. 22, 2023 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody independently developed by the company, in combination with drugs containing fluorouracil and platinum for the first-line treatment of patients with PD-L1 positive unresectable locally advanced/recurrent … Read more
New village embraces Life Time’s ethos for healthy living with 62,000-square-foot athletic club and outdoor amenity deck, along with 290 luxury residences available for lease STAMFORD, Conn., Sept. 22, 2023 /PRNewswire/ — Life Time (NYSE:LTH), the nation’s premier healthy lifestyle brand, today opened its first athletic country club in Connecticut with a nearly 52,000-square foot … Read more
LONDON, Sept. 21, 2023 /PRNewswire/ — Chlamydia Disease is one of the most prevalence sexually transmitted infections. As per a data released by NIH, nearly 4 million cases are registered ever year in US alone. Although it can affect both males and females, irrespective of their age groups, but young women are highly susceptible to this STI. … Read more